1. |
Sung S, Shirazi M, Shu CA, et al. Pulmonary small cell carcinoma: Review, common and uncommon differentials, genomics and management. Diagn Cytopathol, 2020, 48(8): 790-803.
|
2. |
Shin N, Choi JA, Choi JM, et al. Sclerotic changes of cavernous hemangioma in the cirrhotic liver: long-term follow-up using dynamic contrast-enhanced computed tomography. Radiol Med, 2020, 125(12): 1225-1232.
|
3. |
Gentili F, Bronico I, Maestroni U, et al. Small renal masses (≤ 4 cm): differentiation of oncocytoma from renal clear cell carcinoma using ratio of lesion to cortex attenuation and aorta-lesion attenuation difference (ALAD) on contrast-enhanced CT. Radiol Med, 2020, 125(12): 1280-1287.
|
4. |
Mayer P, Giannakis A, Klauß M, et al. Radiological evaluation of pancreatic cancer: What is the significance of arterial encasement >180° after neoadjuvant treatment?. Eur J Radiol, 2021, 137: 109603.
|
5. |
Granata V, Grassi R, Fusco R, et al. Pancreatic cancer detection and characterization: state of the art and radiomics. Eur Rev Med Pharmacol Sci, 2021, 25(10): 3684-3699.
|
6. |
Granata V, Fusco R, Bicchierai G, et al. Diagnostic protocols in oncology: workup and treatment planning. Part 1: the optimitation of CT protocol. Eur Rev Med Pharmacol Sci, 2021, 25(22): 6972-6994.
|
7. |
Garcia-Velloso MJ, Bastarrika G, de-Torres JP, et al. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: diagnostic accuracy of FDG PET/CT. Lung Cancer, 2016, 97: 81-86.
|
8. |
Beroukhim R, Mermel CH, Porter D, et al. The landscape of somatic copy-number alteration across human cancers. Nature, 2010, 463(7283): 899-905.
|
9. |
Albertson DG, Collins C, McCormick F, et al. Chromosome aberrations in solid tumors. Nat Genet, 2003, 34(4): 369-376.
|
10. |
Li YL, Roberts ND, Wala JA, et al. Patterns of somatic structural variation in human cancer genomes. Nature, 2020, 578(7793): 112-121.
|
11. |
Graf RP, Eskander R, Brueggeman L, et al. Association of copy number variation signature and survival in patients with serous ovarian cancer. JAMA Netw Open, 2021, 4(6): e2114162.
|
12. |
Jamal-Hanjani M, Wilson GA, McGranahan N, et al. Tracking the evolution of non-small-cell lung cancer. N Engl J Med, 2017, 376(22): 2109-2121.
|
13. |
Nabavi S, Zare F. Identification of copy number alterations from next-generation sequencing data. Adv Exp Med Biol, 2022, 1361: 55-74.
|
14. |
Meyerson M, Gabriel S, Getz G. Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet, 2010, 11(10): 685-696.
|
15. |
Gu W, Talevich E, Hsu E, et al. Detection of cryptogenic malignancies from metagenomic whole genome sequencing of body fluids. Genome Med, 2021, 13(1): 98.
|
16. |
Liang DS, Peng Y, Lv WG, et al. Copy number variation sequencing for comprehensive diagnosis of chromosome disease syndromes. J Mol Diagn, 2014, 16(5): 519-526.
|
17. |
Liu KL, Gao Y, Han JW, et al. Diffuse large B-cell lymphoma of the mandible diagnosed by metagenomic sequencing: a case report. Front Med (Lausanne), 2021, 8: 752523.
|
18. |
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell, 2011, 144(5): 646-674.
|
19. |
Rao CV, Asch AS, Yamada HY. Emerging links among Chromosome Instability (CIN), cancer, and aging. Mol Carcinog, 2017, 56(3): 791-803.
|
20. |
Li XL, Chen XF, Hu GH, et al. Combined analysis with copy number variation identifies risk loci in lung cancer. Biomed Res Int, 2014, 2014: 469103.
|
21. |
Li TY, Zhang F. Screening of lung cancer related SNPs and CNVs with SNP microarrays. Eur Rev Med Pharmacol Sci, 2015, 19(2): 225-234.
|
22. |
王艳泓, 邱玉英, 唐健, 等. 结合宏基因组二代测序诊断的八例鹦鹉热患者临床分析. 中国呼吸与危重监护杂志, 2021, 20(7): 472-478.
|
23. |
Guo YF, Li HN, Chen HB, et al. Metagenomic next-generation sequencing to identify pathogens and cancer in lung biopsy tissue. EBioMedicine, 2021, 73: 103639.
|